GOUDIS RICHARD 4

Accession 0001209191-18-051483

CIK 0001180262other

View on SEC.gov Company Profile

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 4:36 PM ET

Size

84.6 KB

Accession

0001209191-18-051483

Insider Transaction Report

Form 4

Period: 2018-09-17

HERBALIFE NUTRITION LTD.HLF

GOUDIS RICHARD

Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2018-09-17$22.40/sh+236,852$5,305,485→ 835,191 total
Exercise/Conversion
Common Stock
2018-09-17$39.79/sh+109,322$4,349,922→ 774,657 total
Disposition to Issuer
Common Stock
2018-09-17$55.11/sh−78,934$4,350,053→ 695,723 total
Exercise/Conversion
Common Stock
2018-09-17$29.99/sh+166,804$5,002,452→ 846,616 total
Exercise/Conversion
Common Stock
2018-09-17$23.90/sh+166,500$3,979,350→ 966,931 total
Exercise/Conversion
Common Stock
2018-09-17$31.26/sh+48,532$1,517,110→ 893,890 total
Exercise/Conversion
Common Stock
2018-09-17$15.22/sh+244,698$3,724,304→ 960,736 total
Disposition to Issuer
Common Stock
2018-09-17$55.11/sh−27,526$1,516,958→ 866,364 total
Exercise/Conversion
Common Stock
2018-09-17$28.60/sh+25,508$729,529→ 880,874 total
Disposition to Issuer
Common Stock
2018-09-17$55.11/sh−13,236$729,436→ 867,638 total
Exercise/Conversion
Stock Appreciation Rights
2018-09-17−106,186→ 0 total
Exercise: $11.47From: 2013-05-07Exp: 2020-05-07→ Common Stock (106,186 underlying)
Exercise/Conversion
Stock Appreciation Rights
2018-09-17−166,804→ 0 total
Exercise: $29.99From: 2017-04-30Exp: 2024-04-30→ Common Stock (166,804 underlying)
Exercise/Conversion
Stock Appreciation Rights
2018-09-17−244,698→ 0 total
Exercise: $15.22From: 2018-03-02Exp: 2025-03-02→ Common Stock (244,698 underlying)
Exercise/Conversion
Stock Appreciation Rights
2018-09-17−48,532→ 72,798 total
Exercise: $31.26Exp: 2026-05-09→ Common Stock (48,532 underlying)
Disposition to Issuer
Common Stock
2018-09-17$55.11/sh−22,101$1,217,986→ 613,805 total
Tax Payment
Common Stock
2018-09-17$55.11/sh−15,911$876,855→ 679,812 total
Tax Payment
Common Stock
2018-09-17$55.11/sh−39,804$2,193,598→ 716,038 total
Tax Payment
Common Stock
2018-09-17$55.11/sh−92,723$5,109,965→ 800,431 total
Disposition to Issuer
Common Stock
2018-09-17$55.11/sh−72,209$3,979,438→ 894,722 total
Tax Payment
Common Stock
2018-09-17$55.11/sh−49,364$2,720,450→ 845,358 total
Exercise/Conversion
Stock Appreciation Rights
2018-09-17−109,322→ 0 total
Exercise: $39.79From: 2016-06-21Exp: 2023-12-19→ Common Stock (109,322 underlying)
Disposition to Issuer
Common Stock
2018-09-17$55.11/sh−56,094$3,091,340→ 629,710 total
Disposition to Issuer
Common Stock
2018-09-17$55.11/sh−96,250$5,304,338→ 738,941 total
Exercise/Conversion
Common Stock
2018-09-17$26.65/sh+116,018$3,091,880→ 685,804 total
Tax Payment
Common Stock
2018-09-17$55.11/sh−31,371$1,728,856→ 598,339 total
Tax Payment
Common Stock
2018-09-17$55.11/sh−73,606$4,056,427→ 665,335 total
Disposition to Issuer
Common Stock
2018-09-17$55.11/sh−90,774$5,002,555→ 755,842 total
Exercise/Conversion
Common Stock
2018-09-17$10.33/sh+240,000$2,479,200→ 676,802 total
Exercise/Conversion
Common Stock
2018-09-17$11.47/sh+106,186$1,217,953→ 635,906 total
Disposition to Issuer
Common Stock
2018-09-17$55.11/sh−44,998$2,479,840→ 631,804 total
Tax Payment
Common Stock
2018-09-17$55.11/sh−102,084$5,625,849→ 529,720 total
Tax Payment
Common Stock
2018-09-17$55.11/sh−44,019$2,425,887→ 569,786 total
Disposition to Issuer
Common Stock
2018-09-17$55.11/sh−67,582$3,724,444→ 893,154 total
Tax Payment
Common Stock
2018-09-17$55.11/sh−6,425$354,082→ 861,213 total
Exercise/Conversion
Stock Appreciation Rights
2018-09-17−25,508→ 102,034 total
Exercise: $28.60Exp: 2027-02-27→ Common Stock (25,508 underlying)
Tax Payment
Common Stock
2018-09-17$55.11/sh−10,998$606,100→ 855,366 total
Exercise/Conversion
Stock Appreciation Rights
2018-09-17−240,000→ 0 total
Exercise: $10.33From: 2015-01-04Exp: 2020-01-04→ Common Stock (240,000 underlying)
Exercise/Conversion
Stock Appreciation Rights
2018-09-17−116,018→ 0 total
Exercise: $26.65From: 2014-05-18Exp: 2021-05-18→ Common Stock (116,018 underlying)
Exercise/Conversion
Stock Appreciation Rights
2018-09-17−236,852→ 0 total
Exercise: $22.40From: 2015-05-31Exp: 2022-05-31→ Common Stock (236,852 underlying)
Exercise/Conversion
Stock Appreciation Rights
2018-09-17−166,500→ 0 total
Exercise: $23.90From: 2018-05-07Exp: 2025-05-07→ Common Stock (166,500 underlying)

Footnotes (23)

[F1]The reporting person received 92,918 shares of common stock upon the net exercise of the 240,000 Stock Appreciation Rights ("SARS"). The reporting person forfeited 44,998 shares of common stock underlying the SARS in payment of the exercise price and 102,084 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11.
[F10]The reporting person received 10,008 shares of common stock upon the net exercise of the 48,532 SARS. The reporting person forfeited 27,526 shares of common stock underlying the SARS in payment of the exercise price and 10,998 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11.
[F11]The reporting person received 5,847 shares of common stock upon the net exercise of the 25,508 SARS. The reporting person forfeited 13,236 shares of common stock underlying the SARS in payment of the exercise price and 6,425 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11.
[F12]These SARS were previously reported as covering 120,000 shares at an exercise price of $20.67 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
[F13]These SARS were previously reported as covering 66,366 shares at an exercise price of $22.94 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
[F14]These SARS were previously reported as covering 58,009 shares at an exercise price of $53.29 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
[F15]These SARS were previously reported as covering 118,426 shares at an exercise price of $44.79 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
[F16]These SARS were previously reported as covering 54,661 shares at an exercise price of $79.58 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
[F17]These SARS were previously reported as covering 83,402 shares at an exercise price of $59.98 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
[F18]These SARS were previously reported as covering 122,349 shares at an exercise price of $30.44 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
[F19]These SARS were previously reported as covering 83,250 shares at an exercise price of $47.80 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
[F2]On May 14, 2018, the common stock of Herbalife Nutrition Ltd. split 2-for-1, resulting in the reporting person's acquisition of 218,401 additional shares of common stock.
[F20]On May 9, 2016, the reporting person was granted 60,665 SARs. These SARs vested 20% each on May 9, 2017 and May 9, 2018, and 60% will vest on May 9, 2019.
[F21]These SARS were previously reported as covering 60,665 shares at an exercise price of $62.51 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
[F22]On February 27, 2017, the reporting person was granted 63,771 SARs. These SARs vested 20% on February 27, 2018 and 20% will vest on February 27, 2019 and 60% will vest on February 27, 2020.
[F23]These SARS were previously reported as covering 63,771 shares at an exercise price of $57.19 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
[F3]The reporting person received 40,066 shares of common stock upon the net exercise of the 106,186 SARS. The reporting person forfeited 22,101 shares of common stock underlying the SARS in payment of the exercise price and 44,019 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11.
[F4]The reporting person received 28,553 shares of common stock upon the net exercise of the 116,018 SARS. The reporting person forfeited 56,094 shares of common stock underlying the SARS in payment of the exercise price and 31,371 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11.
[F5]The reporting person received 66,996 shares of common stock upon the net exercise of the 236,852 SARS. The reporting person forfeited 96,250 shares of common stock underlying the SARS in payment of the exercise price and 73,606 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11.
[F6]The reporting person received 14,477 shares of common stock upon the net exercise of the 109,322 SARS. The reporting person forfeited 78,934 shares of common stock underlying the SARS in payment of the exercise price and 15,911 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11.
[F7]The reporting person received 36,226 shares of common stock upon the net exercise of the 166,804 SARS. The reporting person forfeited 90,774 shares of common stock underlying the SARS in payment of the exercise price and 39,804 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11.
[F8]The reporting person received 84,393 shares of common stock upon the net exercise of the 244,698 SARS. The reporting person forfeited 67,582 shares of common stock underlying the SARS in payment of the exercise price and 92,723 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11.
[F9]The reporting person received 44,927 shares of common stock upon the net exercise of the 166,500 SARS. The reporting person forfeited 72,209 shares of common stock underlying the SARS in payment of the exercise price and 49,364 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on September 17, 2018 of $55.11.

Documents

2 files

Issuer

HERBALIFE NUTRITION LTD.

CIK 0001180262

→

Entity typeother

Related Parties

filerCIK 0001311175

Filing Metadata

Form type: 4
Filed: Sep 17, 8:00 PM ET
Accepted: Sep 18, 4:36 PM ET
Size: 84.6 KB

View on SEC.gov